Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (1111-1120 of 1,350) with videos related to

Pageof 135
Sort By:
Drug Development Research|December 5, 2022
A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancerTurana Orujova, Abdulilah Ece, Gülşen Akalın Çiftçi, et al.
Drug Development Research|December 9, 2022
Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cellsRie Ando-Matsuoka, Kenta Yagi, Mayu Takaoka, et al.
Drug Development Research|November 30, 2019
Autophagy induction in the treatment of Alzheimer's diseaseEran Schmukler, Ronit Pinkas-Kramarski
Drug Development Research|November 2, 2019
Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patientsSeyed Shahabeddin Mortazavi-Jahromi, Mona Aslani, Saiedeh Omidian, et al.
Drug Development Research|July 26, 2021
The PD-1/PD-L1 binding inhibitor BMS-202 suppresses the synthesis and secretion of gonadotropins and enhances apoptosis via p38 MAPK signaling pathwayYing Jiang, Jinglin Zhang, Jingtao Qiu, et al.
Drug Development Research|July 6, 2021
Circ_0001667 knockdown blocks cancer progression and attenuates adriamycin resistance by depleting NCOA3 via releasing miR-4458 in breast cancerYanfei Cui, Jing Fan, Wenbo Shi, et al.
Drug Development Research|July 22, 2021
Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigationsSuat Sari, Burak Barut, Monika Marcinkowska, et al.
Drug Development Research|December 30, 2020
Oridonin alleviates d-GalN/LPS-induced acute liver injury by inhibiting NLRP3 inflammasomeTao Zhang, Yulian Chen, Zhikun Zhan, et al.
Drug Development Research|January 5, 2021
In silico design and synthesis of N-arylalkanyl 2-naphthamides as a new class of non-purine xanthine oxidase inhibitorsSheau Ling Ho, Ching-Ting Lin, Shoei-Sheng Lee
Drug Development Research|December 19, 2020
Design, synthesis, in vitro and in silico studies of novel Schiff base derivatives of 2-hydroxy-4-methoxybenzamide as tyrosinase inhibitorsAida Iraji, Zahra Panahi, Najmeh Edraki, et al.
Pageof 135

Showing results (1111-1120 of 1,350) with videos related to

Sort By:
Pageof 135
Drug Development Research|December 5, 2022
A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancerTurana Orujova, Abdulilah Ece, Gülşen Akalın Çiftçi, et al.
Drug Development Research|December 9, 2022
Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cellsRie Ando-Matsuoka, Kenta Yagi, Mayu Takaoka, et al.
Drug Development Research|November 30, 2019
Autophagy induction in the treatment of Alzheimer's diseaseEran Schmukler, Ronit Pinkas-Kramarski
Drug Development Research|November 2, 2019
Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patientsSeyed Shahabeddin Mortazavi-Jahromi, Mona Aslani, Saiedeh Omidian, et al.
Drug Development Research|July 26, 2021
The PD-1/PD-L1 binding inhibitor BMS-202 suppresses the synthesis and secretion of gonadotropins and enhances apoptosis via p38 MAPK signaling pathwayYing Jiang, Jinglin Zhang, Jingtao Qiu, et al.
Drug Development Research|July 6, 2021
Circ_0001667 knockdown blocks cancer progression and attenuates adriamycin resistance by depleting NCOA3 via releasing miR-4458 in breast cancerYanfei Cui, Jing Fan, Wenbo Shi, et al.
Drug Development Research|July 22, 2021
Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigationsSuat Sari, Burak Barut, Monika Marcinkowska, et al.
Drug Development Research|December 30, 2020
Oridonin alleviates d-GalN/LPS-induced acute liver injury by inhibiting NLRP3 inflammasomeTao Zhang, Yulian Chen, Zhikun Zhan, et al.
Drug Development Research|January 5, 2021
In silico design and synthesis of N-arylalkanyl 2-naphthamides as a new class of non-purine xanthine oxidase inhibitorsSheau Ling Ho, Ching-Ting Lin, Shoei-Sheng Lee
Drug Development Research|December 19, 2020
Design, synthesis, in vitro and in silico studies of novel Schiff base derivatives of 2-hydroxy-4-methoxybenzamide as tyrosinase inhibitorsAida Iraji, Zahra Panahi, Najmeh Edraki, et al.
Pageof 135